These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 29116399)

  • 1. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
    Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma.
    Tatsumi T; Yamamoto S; Uehara J; Sugawara T; Baba T; Inoue M; Hata H; Mitamura Y
    Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1355-60. PubMed ID: 23250484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.
    Olmos LC; Sayed MS; Moraczewski AL; Gedde SJ; Rosenfeld PJ; Shi W; Feuer WJ; Lee RK
    Eye (Lond); 2016 Mar; 30(3):463-72. PubMed ID: 26681145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic use of bevacizumab to avoid anterior segment neovascularization following proton therapy for uveal melanoma.
    Mantel I; Schalenbourg A; Bergin C; Petrovic A; Weber DC; Zografos L
    Am J Ophthalmol; 2014 Oct; 158(4):693-701.e2. PubMed ID: 25034116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma.
    Nagendran ST; Finger PT
    Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):201-7. PubMed ID: 25707045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
    Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
    Eid TM; Radwan A; el-Manawy W; el-Hawary I
    Can J Ophthalmol; 2009 Aug; 44(4):451-6. PubMed ID: 19606170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up.
    Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP
    Acta Ophthalmol; 2015 Feb; 93(1):e1-6. PubMed ID: 24989855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study.
    Sasamoto Y; Oshima Y; Miki A; Wakabayashi T; Song D; Matsushita K; Hamasaki T; Nishida K
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):41-8. PubMed ID: 21992534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
    Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
    Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.
    Riechardt AI; Pilger D; Cordini D; Seibel I; Gundlach E; Hager A; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2263-2269. PubMed ID: 28721444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab.
    Wittström E; Holmberg H; Hvarfner C; Andréasson S
    Eur J Ophthalmol; 2012; 22(4):563-74. PubMed ID: 22139613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma.
    Ciftci S; Sakalar YB; Unlu K; Keklikci U; Caca I; Dogan E
    Eur J Ophthalmol; 2009; 19(6):1028-33. PubMed ID: 19882572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab for neovascular glaucoma.
    Vasudev D; Blair MP; Galasso J; Kapur R; Vajaranant T
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):453-8. PubMed ID: 19857107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
    Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
    Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma.
    Ha JY; Lee TH; Sung MS; Park SW
    Korean J Ophthalmol; 2017 Dec; 31(6):538-547. PubMed ID: 29022296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcome of Intravitreal Bevacizumab Followed by Ahmed Valve Implantation in the Management of Neovascular Glaucoma.
    Tailor R; Kinsella MT; Clarke JC
    Semin Ophthalmol; 2018; 33(5):606-612. PubMed ID: 28992424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
    Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
    J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.